Concepedia

Behavioral and pathological outcomes in MOG 35–55 experimental autoimmune encephalomyelitis

Melina Jones, Thien T. Nguyen, Cynthia A. DeBoy, John W. Griffin, Katherine A. Whartenby, Douglas A. Kerr, Peter A. Calabresi

Journal of Neuroimmunology · 2008 · 95 citations · 25 references

DOI

Concepts

References

25

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

Ted Yednock, Catherine Cannon, Lawrence C. Fritz et al. · Nature · 1992 · 1.7K citations

, , +12

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

Sha Mi, Bing Hu, Kyungmin Hahm et al. · Nature Medicine · 2007 · 487 citations

, , +14

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

Terence Smith, Anthony Groom, Bin Zhu et al. · Nature Medicine · 2000 · 466 citations

, , +14

Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice

Deming Sun, John N. Whitaker, Zhigang Huang et al. · The Journal of Immunology · 2001 · 446 citations · Full text

, , +17